UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000033619
Receipt number R000038336
Scientific Title A study for the effect of intake of food derived from microorganism on eye strain
Date of disclosure of the study information 2020/05/31
Last modified on 2020/06/29 19:53:44

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

A study for the effect of intake of food derived from microorganism on eye strain

Acronym

A study for the effect of intake of food derived from microorganism on eye strain

Scientific Title

A study for the effect of intake of food derived from microorganism on eye strain

Scientific Title:Acronym

A study for the effect of intake of food derived from microorganism on eye strain

Region

Japan


Condition

Condition

None (Healthy adults)

Classification by specialty

Adult

Classification by malignancy

Others

Genomic information

NO


Objectives

Narrative objectives1

To evaluate the effect of intake of food derived from microorganism on eye strain

Basic objectives2

Efficacy

Basic objectives -Others


Trial characteristics_1


Trial characteristics_2


Developmental phase



Assessment

Primary outcomes

Tests for eye strain

Key secondary outcomes

Questionnaires


Base

Study type

Interventional


Study design

Basic design

Parallel

Randomization

Randomized

Randomization unit

Individual

Blinding

Double blind -all involved are blinded

Control

Placebo

Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms

2

Purpose of intervention

Prevention

Type of intervention

Food

Interventions/Control_1

Capsule containing food derived from microorganism, once a day for 8 weeks

Interventions/Control_2

Capsule not containing food derived from microorganism, once a day for 8 weeks

Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

35 years-old <=

Age-upper limit

50 years-old >

Gender

Male and Female

Key inclusion criteria

(1) Healthy Japanese men and women aged from 35 to less than 50 years old
(2) Subjects with subjective eye strain
(3) Subjects who are judged as suitable for this study by the investigator

Key exclusion criteria

(1) Subjects who are under treatment of or have history of cancer, heart failure and myocardial infarction
(2) Subjects who are under treatment of or have history of chronic diseases
(3) Subjects who are diagnosed with or aware of presbyopia
(4) Subjects who have eye disease
(5) Subjects who are diagnosed with asthenopia
(6) Subjects who use eye drops for eye disease
(7) Subjects who have an uncorrected serious refractive error
(8) Subjects who had LASIK surgery
(9) Subjects who have serious astigmatism
(10) Subjects who have amblyopia or strabismus
(11) Subjects whose best-corrected visual acuity is < 1.0
(12) Subjects who are diagnosed with eye strain caused by anything except for neurogenic or adjust function
(13) Subjects who work in a company developing functional foods
(14) Subjects with excessive alcohol-drinking
(15) Subjects who can't stop drinking alcohol for 2 days until the check days
(16) Subjects who usually take or will take drugs or health foods for eye
(17) Subjects who can't stop take drugs or health foods for regulation of immune functions
(18) Subjects who can't stop eating foods similar to the test foods and/or can't stop taking drugs or health foods including lactic acid bacteria or Bifidobacterium
(19) Subjects who have tendency to get diarrhea by eating dairy products
(20) Subjects who have risk to develop allergy caused by foods or drugs
(21) Subjects who have drug dependence or allergy dependence
(22) Subjects who are diagnosed with hay fever
(23) Subjects who can't complete workload for eye strain
(24) Subjects who are not suitable for this study by results of lifestyle questionnaire
(25) Subjects who are or are planning to be pregnant or breastfeeding during this study
(26) Subjects who participated in other clinical trial within 3 months prior to obtaining informed consent, or are planning to participate other clinical trial
(27) Subjects who are judged as unsuitable for participating this study by the investigator

Target sample size

80


Research contact person

Name of lead principal investigator

1st name
Middle name
Last name Yuji Morita

Organization

Kirin Company, Limited

Division name

Research Laboratories for Health Science & Food Technologies, Research & Development Division

Zip code


Address

1-13-5, Fukuura Kanazawa-ku, Yokohama, Kanagawa Japan

TEL

045-788-7200

Email

Yuji_Morita@kirin.co.jp


Public contact

Name of contact person

1st name
Middle name
Last name Naoko Suzuki

Organization

ORTHOMEDICO Inc.

Division name

R&D Department

Zip code


Address

2F Sumitomo Fudosan Korakuen Bldg., 1-4-1, Koishikawa, Bunkyo-ku, Tokyo, Japan

TEL

03-3818-0610

Homepage URL


Email

nao@orthomedico.jp


Sponsor or person

Institute

ORTHOMEDICO Inc.

Institute

Department

Personal name



Funding Source

Organization

Kirin Company, Limited

Organization

Division

Category of Funding Organization

Profit organization

Nationality of Funding Organization



Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization


Address


Tel


Email



Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions

アリオ西新井クリニック眼科(東京)


Other administrative information

Date of disclosure of the study information

2020 Year 05 Month 31 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled


Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Completed

Date of protocol fixation

2018 Year 07 Month 30 Day

Date of IRB

2018 Year 07 Month 30 Day

Anticipated trial start date

2018 Year 08 Month 03 Day

Last follow-up date

2019 Year 03 Month 29 Day

Date of closure to data entry


Date trial data considered complete


Date analysis concluded



Other

Other related information



Management information

Registered date

2018 Year 08 Month 03 Day

Last modified on

2020 Year 06 Month 29 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000038336